Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$KRTL As a result, KRTL International Corp assisted its partner, Fortune, Nickel, and Gold Inc., successfully advance the exploration on its Gowan and Beck-Ottaway Properties in Ontario through the services of Axiom Exploration Group Ltd. ("Axiom") of Saskatoon, Sask
$KRTL Kelly Fenemore, CEO of Medflow, also shares this enthusiasm. "We are thrilled to partner with KRTL Biotech, a company that shares our commitment to innovation and patient care. This partnership reinforces our mission to provide secure and accessible telemedicine services to patients everywhere."
https://seekingalpha.com/pr/19349677-krtl-partnered-to-bring-comprehensive-cloud-and-endpoint-security-and-ai-powered-telemedicine
$HMBL These investments are part of a broader restructuring plan to recapitalize the company, consolidate and retire existing debt and reduce dilution. This restructuring is designed to drive shareholder value and strengthen the balance sheet of the company.
“HUMBL is executing on its core product lines in both its consumer and commercial divisions, and we are ready to drive forward to scaling our revenues through expanded sales and technology bandwidth,” said Brian Foote, CEO of HUMBL. “The capitalization of the company is critical, along with a comprehensive restructuring of debt and share classes, as well as reducing dilution in an effort to drive value for shareholders and prepare the company for uplisting to a major exchange.”
$HMBL was the first digita walet partner of a fine four NCAA basketball program.
$HMBL The commercial division has the first government approved wallet in the U.S.
$HMBL is cosing six figures of commercia revenue already in Latin America.
$HMBL also sold 100,000,000 shares of common stock and warrants to purchase 100,000,000 shares of common stock for a period of five years at $0.005 to a group of investors for $220,000. The proceeds will be used for general business operations. More information regarding the transaction will be provided in a Form 8-K to be filed with the SEC.
https://www.morningstar.com/news/globe-newswire/8839965/humbl-receives-funding-commitment-of-up-to-21-million-as-an-initial-step-in-a-comprehensive-plan-to-recapitalize-the-company-and-pursue-uplisting-to-a-major-exchange
$HMBL also sold 100,000,000 shares of common stock and warrants to purchase 100,000,000 shares of common stock for a period of five years at $0.005 to a group of investors for $220,000. The proceeds will be used for general business operations. More information regarding the transaction will be provided in a Form 8-K to be filed with the SEC.
https://www.morningstar.com/news/globe-newswire/8839965/humbl-receives-funding-commitment-of-up-to-21-million-as-an-initial-step-in-a-comprehensive-plan-to-recapitalize-the-company-and-pursue-uplisting-to-a-major-exchange
$HMBL In addition to the investment made by Pacific Lion in HUMBL, the company will also be working with Pacific Lion, a firm that specializes in delivering strategic direct investments and hands-on advisory services to help with the growth of early stage companies. The firm focuses on strategies that help capitalize public companies via retail and institutional investors, along with crowdfunding, equity lines and M+A consulting, with the goal of direct uplistings to a major exchange over a 6-18 month targeted time frame.
“We believe that HUMBL has developed an early-mover advantage in providing Web 3 digital wallets, products and services to consumer and government clients,” said Jacob Fernane, CEO of Pacific Lion. “We believe our access to strategic funding, share structure cleanup, technology and operations augmentation, and more, will allow HUMBL to scale to the levels needed for a major exchange uplist and to rejuvenate its powerful retail shareholder base.”
$CBGL Technical Analysis https://www.barchart.com/stocks/quotes/CBGL/technical-analysis
$CBGL Traders Cheat Sheet https://cannabisglobalinc.com/new-brand-botan/
$CBGL LOS ANGELES, May 02, 2023 (GLOBE NEWSWIRE) -- Cannabis Global, Inc. (OTC PINK: CBGL), a licensed Los Angeles-based manufacturer and distributor in the cannabis sector, and KRTL International Corp., today announced, an exclusive distribution agreement for Huella Singani in California. Under the terms of the agreement, CBGL will partner with KRTL to be the exclusive distributor of Huella Singani in California.
https://finance.yahoo.com/news/cannabis-global-krtl-international-corp-133000841.html
$CBGL Technical Analysis https://www.barchart.com/stocks/quotes/CBGL/technical-analysis
$CBGL Company Profile https://www.otcmarkets.com/stock/CBGL/profile
$CBGL is a global player in the fast growing and highly lucrative cannabis marketplace headquartered in bustling Downtown Los Angeles, California. The Company will be involved in both the industrial hemp markets, where permitted and legal under the 2018 Farm Bill, and the legal marijuana markets as permitted and licensed by way of various state and local laws and regulations.
$CAFI NMN Promising Compound
Twitter
https://tinyurl.com/2p9e48zm
$CBGL Cannabis Global Completes Significant Debt Cancellations in Q1 - Over $800K in Debt Extinguishment - Actively Negotiating Additional Debt Settlements
https://feeds.issuerdirect.com/news-release.html?newsid=7256443189477382
$CBGL Company Profile https://www.otcmarkets.com/stock/CBGL/profile
$EMED When it comes to electricity created in the human body, the energy source is chemical and has to do with the composition of the atoms and molecules present. All the elements we take into our bodies, such as oxygen, sodium, potassium, calcium, magnesium etc., have a specific electrical charge. How those molecules are bound together and how they react to other molecules near them is how chemicals create energy. Some of these electrical impulses found naturally in our bodies activate functions needed for healing.
$EMED Electrotherapy can be used to treat a wide range of of acute and chronic pain.
It also supports healing and recovering and can be used for post-surgical discomfort and to boost your body’s natural recovery properties.
$EMED Electricity enables information to circulate in the body, electrotherapy manipulates a specific part of the information by pulsating electrical waves interfering with the transmission of pain signals.
Our nervous system is composed of our brain and our spinal cord, which combine to form the central nervous system; and our sensory and motor nerves, which form the peripheral nervous system. Nerves send information about what is happening in our environment to the brain via the spinal cord. The brain then sends information back to our nerves, helping us to perform actions in response. By treating specific body areas and varying frequency, wavelength and intensity applied, electrotherapy devices can manipulate impulses and target actions to alleviate pain or they can disrupt pain signals.
$EMED As the Company moves closer to production of the new next-generation flagship device, management plans to offer a special upgrade and exchange program to existing clients, which will be bundled with a lifetime warranty.
$EMED Electrotherapy is a nerve stimulation therapy via carefully developed electrical impulses mimicking our
body signals to help restore damages caused by injuries or accidents.
Significant percentage of patients found TENS devices effectively reduced their pain.
https://electromedtech.com/electrotherapy-explained/
$EMED Matthew Wolfson, Founder and CEO commented, "Q4 was a breakout quarter. We saw topline sales jump in response to further expansion in our brand awareness and sales & marketing performance. Overall, it was our best quarter since we went public and provides strong market feedback that our next-generation R&D and market positioning represents the start of an exciting new chapter for Electromedical. And the path is only going to get more exciting as we get ready to launch our revolutionary Infinity device."
$EMED Electricity enables information to circulate in the body, electrotherapy manipulates a specific part of the information by pulsating electrical waves interfering with the transmission of pain signals.
Our nervous system is composed of our brain and our spinal cord, which combine to form the central nervous system; and our sensory and motor nerves, which form the peripheral nervous system. Nerves send information about what is happening in our environment to the brain via the spinal cord. The brain then sends information back to our nerves, helping us to perform actions in response. By treating specific body areas and varying frequency, wavelength and intensity applied, electrotherapy devices can manipulate impulses and target actions to alleviate pain or they can disrupt pain signals.
$EMED Electrotherapy is a nerve stimulation therapy via carefully developed electrical impulses mimicking our
body signals to help restore damages caused by injuries or accidents.
Significant percentage of patients found TENS devices effectively reduced their pain.
https://electromedtech.com/electrotherapy-explained/
$EMED Electrotherapy is a nerve stimulation therapy via carefully developed electrical impulses mimicking our
body signals to help restore damages caused by injuries or accidents.
Significant percentage of patients found TENS devices effectively reduced their pain.
https://electromedtech.com/electrotherapy-explained/
$EMED Matthew Wolfson, Founder and CEO commented, "Q4 was a breakout quarter. We saw topline sales jump in response to further expansion in our brand awareness and sales & marketing performance. Overall, it was our best quarter since we went public and provides strong market feedback that our next-generation R&D and market positioning represents the start of an exciting new chapter for Electromedical. And the path is only going to get more exciting as we get ready to launch our revolutionary Infinity device."
$EMED Electrotherapy is a nerve stimulation therapy via carefully developed electrical impulses mimicking our
body signals to help restore damages caused by injuries or accidents.
Significant percentage of patients found TENS devices effectively reduced their pain.
https://electromedtech.com/electrotherapy-explained/
$EMED Preliminary revenue for the twelve months ended Dec 31 was approximately $1.15 million, which represents a total increase in sales of 26.7% on a year-over-year basis.
$EMED Electromedical’s commitment to create long-lasting drug-free solutions to pain management is honored by the development of The WellnessPro Plus®, a technologically advanced TENS (transcutaneous electrical nerve stimulation) therapy device focusing on pain relief.
$EMED Preliminary revenue for the twelve months ended Dec 31 was approximately $1.15 million, which represents a total increase in sales of 26.7% on a year-over-year basis.
$EMED
The WellnessPro Plus®
triggers our body’s natural processes. Electrical impulses travel from nerves around the injured area to our brain, delivering the unpleasant sensation of pain. WellnessPro Plus® operates by disrupting these pain signals received by our synapses, mimicking our natural electric signals to relieve patients from pain.
Electromedical Technologies brought together some of the leading biomedical researchers from around the world to develop next generation TENS machines. Through product innovation and a forward-thinking approach, we succeeded to develop specific algorithms in electrotherapy that work to alleviate pain.
$CLNV follow us on Twitter: @CleanVisionCorp
$EMED Preliminary revenue for the twelve months ended Dec 31 was approximately $1.15 million, which represents a total increase in sales of 26.7% on a year-over-year basis.
$APSI is an OTC Pink Stock that has already filed for an up-list to OTC QB exchange and whose ultimate goal is a NASDAQ listing.
Business Description:
$Robertscott Thanks - - GOD'S $Gold On Fire - $NEWS - $Monument Reports Second Quarter Fiscal 2023 ("Q2
FY2023") Results
March 1, 2023
View PDF
Gross Revenue of US$5.87 Million and Cash Cost of US$1,507/Oz
Vancouver, B.C., March 1, 2023, Monument Mining Limited (TSX-V: MMY and FSE: D7Q1)
“Monument” or the “Company” today announced its production and financial results for the
second quarter of fiscal 2023 and the six months ended December 31, 2022.
All amounts are expressed in United States dollars (“US$”) unless otherwise indicated
(refer to www.sedar.com for full financial results).
President and CEO Cathy Zhai commented, “I am pleased to report during the second
quarter our Selinsing Gold Mine has filtered first gold concentrates with completion of
dry/wet flotation plant commissioning.
The ramp up period commenced subsequent to the second quarter yet to bring the project
to commercial production.”
Second Quarter Highlights:
https://monumentmining.com/news-media/news/2023/monument-reports-second-quarter-fiscal-2023-q2-fy2023-results/
Gold Production @ Low Cost & Very Undervalued Bargain - Thanks -
WELL; Monument Mining HAVE 3 GOLD MILLS NOW - And )
Selinsing have One BIOX and One New SULPHIDE - )
Well Monument Mining have produced 1000 Gold Bars - )
and the next 1000 Gold Bars should go much faster with the new MILL - )
https://monumentmining.com/news-media/photo-gallery/
RE: NEWS - Monument Mining President and CEO Cathy Zhai
commented, “During commissioning we have identified some
bottlenecks and are working with Mincore to fix them.
Up to date the flotation plant has delivered saleable concentrate of approximately
1,707 dry tonnes at 35.12 g/t Au with gold content of 1,928 troy ounces. )
Figure 2. Plant Inspection
https://www.globenewswire.com/news-release/2023/02/27/2616400/0/en/Monument-Progresses-Flotation-Commissioning-at-Selinsing.html
As of February 22nd, 2023, a total of 1,707 dry metric tonnes of gold concentrate have been
produced with an average gold grade of 35.12 g/t Au (1,928 troy ounces).
A fast Production Gold Au Estimate DD by a Monument Mining Investor: -
Ex.gracia -
Scoping of concentrate Production…52,000 ounces
We have some very interesting tidbit provided in todays NR which can be combined with
FS information to scope out annual concentrate production
...950,000 tons of mill feed per year ( about 3000 tpd )
....Mass pull of 5% ( ie 100 tons of ore is concentrated by a factor of 20 to 5 tons of
concentrate )
..head .grade of 1.95 gms per ton ( oxides removed )
....recovery of 85%
So , we have 1.95 gms/ ton. X 20 X 85 % = 35 gms per ton which is spot on the
performance reported today.
950,000 tons of head feed is concentrated by a factor of 20 ( ie Mass pull of 5% ) to 47000
tons of concentrate containing 1.1 ounces of gold per ton .
This computes to about 52,000 ounces of gold per year contained within 47000 tons of gold
concentrate
The Feasability Study included Biox and also oxides .
It quoted 60.000 ounces per year in the initial years of production .
So, removing the oxides from the mill feed and 53,000 ounces of sulphide gold produced
per year seems quite good and meets breast plate production rates.
Reducing production by about 10 % for smelting and transportation costs and our net gold
sales will be about 48,000 ounces per year which at current POG of $2259 CAD per ounce
will result in about $105 million CAD in annual revenues.
The FSR analyst report calculated a 30% cash flow margin which is just over $30 million
CAD per year.
As we have nearly $45 million US in forward non capital tax loss pools to offset income
taxes, that amount ($30 m CAD ) is essentially free cash flows.
There will be need for sustaining capital , so remove $5 million for that and we have about
$25 million or about $0.08 per share in free cash flows or equivalently in the absence of
taxes, net earnings
This gets us to about book value of $0.48 per share at a very modest 6 times annual
earnings
So todays NR provided an excellent insight into our FP production outlook .
As importantly , it confirms and conforms quite well with the 2019 Feasability Study which is
quite reassuring.
Considering that we have over $75 million in asset value in our Murchison
Project, Monument is now a screaming buy.
" As of February 22, 2023, a total of 1,707 tonnes of flotation concentrate have been
produced at an average grade of 35.12 g/t Au...1928 ounces of gold"
Comment on this Post
(All time best to make your own DD)
Welcome ; Can we produce/ sell 10,000 ounces in Q3
Q3 is this quarter ending March 31/23.
We have 30 days in March to do so .
Head feed is 3000 tons per day, so if all goes well, we should
produce 90,000 tons of ore in March.
With a mass pull of 5%, that will result in about 4500 tons of
concentrate , containing 1.1 ounces per ton which is
about 5000 ounces of gold.
We have already produced 1829 ounces to date during ramp it ,
up to a week or so ago.
Now, we have ....recalling from memory ..about 3000+ ounces of
bullion in Inventory that was saved from Q2 and
Q3 production in F22..
So, with breast plate production of about 5000 ounces for
March....if no more significant hiccups.. and
nearly 2000 ounces in the bag already ,
along with over 3000 ounces of bullion in our vaults,
we could see up to 10,000 ounces sold in Q3...?..if
all going good -
About $23 million in gross sales .
The FSR projected 22,000 ounces in F 2023.
That looks reasonably certain right now....if ramp up proceeds
without any major hiccups.
This is the best news we have had - so.. more Great PR NEWS
this week at PDAC should be made -
Company Profile & Information (TSXV:MMY)
Contact Information
Address
1100 Melville Street, Suite 1580, Vancouver, BC, CA, V6E 4A6
Telephone
+1 604 638-1661
Website
http://www.monumentmining.com
Fax
+1 604 638-1663
Email
info@monumentmining.com
Details
CEO
Cathy Zhai
Issue Type
Common Stock
ISOCFI
ESVUFR
Auditor
GRANT THORNTON LLP
Last Audit
Unqualified Opinion
Well we have produced 1000 Gold Bars - )
and the next 1000 should go much faster with the new MILL - )
https://monumentmining.com/news-media/photo-gallery/
Conglomerate $MBHCF reinvests in community with ESG awards. They're expanding their global outreach from the UK and also Singapore.
https://twitter.com/MBH_Corporation/status/1631276327574667264?s=20
$BLEG Company just posted this:
https://twitter.com/BrandedLegacy/status/1630934615467732994?s=20
Looks like things are picking up. Its rare to see a Company putting in the work they are with this amazing share structure.
These are the gems. When they run, oh they run!!!!!!
GLTA
$NBIO Phase I reinforced the companies' determination and excitement around this unique monoclonal antibody treatment approach and Phase I has shown that it can be given safely at high doses. This is a new pathway toward attacking one of the defining health challenges we face, with longer-term implications that transcend the brain cancer market. We look forward to the opportunity to see our unique R&D platform become a game changer for patients suffering from brain cancer.
$PVSP On watch